Company profile: SARcode Bioscience
1.1 - Company Overview
Company description
- Provider of a novel class of small-molecule LFA-1 (CD11a/CD18; αLβ2) antagonists in development as topical agents to address significant unmet medical needs in ophthalmology, dermatology and inflammatory diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SARcode Bioscience
AB2 Bio
HQ: Switzerland
Website
- Description: Provider of drug discovery and development of best-in-class therapies for inflammatory diseases, including Tadekinig alfa, a recombinant IL-18 binding protein restoring the IL-18/IL-18BP balance; a proprietary assay to detect and measure free IL-18; and clinical programs in primary HLH (Phase III), secondary HLH/MAS, and adult-onset Still's disease (Phase II).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AB2 Bio company profile →
Flame Biosciences
HQ: United States
Website
- Description: Provider of clinical-stage therapies for cancer and other inflammatory diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Flame Biosciences company profile →
Kadmon
HQ: United States
Website
- Description: Provider of biopharmaceutical products and services for the treatment and management of hepatitis C, including Ribasphere RibaPak (ribavirin, USP) tablets that reduce pill burden and deliver treatment biologically equivalent to other ribavirin medications, and INFERGEN (interferon).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kadmon company profile →
Accentia Biopharmaceuticals
HQ: United States
Website
- Description: Provider of immunotherapies for autoimmune-related diseases and cancer; services include hospice care providing emotional support and professional medical help to terminally ill patients, and hypnosis therapy to help patients and families deal with emotional stress, improve communication, and build stronger relationships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Accentia Biopharmaceuticals company profile →
Q32 Bio
HQ: United States
Website
- Description: Provider of therapies for severe autoimmune and inflammatory diseases, including bempikibart (ADX-914), a fully human anti–IL-7 receptor alpha antagonist monoclonal antibody that blocks IL-7 and TSLP signaling to re-regulate adaptive immune function, and ADX-097, a humanized anti-C3d monoclonal antibody fusion protein aimed at restoring complement regulation via a tissue-targeted mechanism.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q32 Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SARcode Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SARcode Bioscience
2.2 - Growth funds investing in similar companies to SARcode Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SARcode Bioscience
4.2 - Public trading comparable groups for SARcode Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →